Therakind
London, United Kingdom· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $1.5M
Overview
Develops pediatric-appropriate small molecule medicines to address unmet needs in children's health.
PediatricsNeurology
Technology Platform
Specialized pharmaceutical formulation platform for developing age-appropriate, palatable, and accurate pediatric dosage forms of small molecule drugs.
Funding History
2Total raised:$1.5M
Seed$1.5M
GrantUndisclosed
Opportunities
Growing regulatory emphasis (like Pediatric Investigation Plans in the EU) creates a strong demand for specialized pediatric formulation services and products.
Risk Factors
Revenue is heavily dependent on successful partnerships with larger pharma companies and navigating complex, region-specific pediatric regulatory requirements.
Competitive Landscape
Operates in a specialized niche with limited direct competitors, though it faces challenges from generic drug makers and the general inertia of the pharmaceutical industry in pediatric development.